Showing 3081-3090 of 5128 results for "".
Rezpegaldesleukin for the Treatment of Atopic Dermatitis
https://practicaldermatology.com/videos/skin-minute/rezpegaldesleukin-for-the-treatment-of-atopic-dermatitis/61143/Dr. Jonathan Silverberg talks about the maintenance data from REZOLVE-AD trial showing lasting efficacy in patients treated with rezpegaldesleukin across several disease measurements of atopic dermatitis (AD).Exploring Dupilumab's Impact on Growth in Pediatric Atopic Dermatitis
https://practicaldermatology.com/programs/practical-dermatology-type-ii-inflammation-journal-club/exploring-dupilumabs-impact-on-growth-in-pediatric-atopic-dermatitis/50962/Practical Dermatology Associate Medical Editor Elizabeth (Lisa) Swanson, MD, FAAD, and Michelle Tarbox, MD, FAAD, discuss emerging evidence and real-world experiences demonstrating how effective control of atopic dermatitis with dupilumab may support healthy growth and development in pediatric patiePrurigo Nodularis in Skin of Color: Recognizing Distinct Clinical Presentations
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/prurigo-nodularis-in-skin-of-color-recognizing-distinct-clinical-presentations/57012/Cheri Frey, MD, discusses how prurigo nodularis may present differently in patients with skin of color, highlighting diagnostic challenges, variations in inflammation, and the importance of recognizing disease manifestations across diverse skin tones.TOGETHER-PsO: Dual Therapy for Psoriasis and Obesity
https://practicaldermatology.com/videos/skin-minute/together-pso-dual-therapy-for-psoriasis-and-obesity/57262/Mark G. Lebwohl, MD, provides key takeaways and commentary on the results of the TOGETHER-PsO study, which looked at a combination therapy of ixekizumab (Taltz) and tirzepatide (Zepbound) in patients with both psoriasis and obesity.Leaders in Dermatology
https://practicaldermatology.com/conferences/noah-worcester/leaders-in-dermatology/57075/Lawrence Green, MD, explains what makes the Noah Worcester Dermatological Society’s Annual Meeting unique and what some of the highlights of the 2026 meeting were.Wound Closure After Mohs Surgery
https://practicaldermatology.com/conferences/maui-derm-hawaii-2026/wound-closure-after-mohs-surgery/54648/Anna Bar, MD, discusses key takeaways from the “Wound Closures” workshop at Maui Derm Hawaii 2026.Turning Acne Treatment Strategies Upside-Down
https://practicaldermatology.com/conferences/maui-derm-hawaii-2026/turning-acne-treatment-strategies-upside-down/54645/Julie Harper, MD, discusses key takeaways from the “Acne and Rosacea: Update 2026” session at Maui Derm Hawaii 2026.Strategies for Treating Patients on GLP-1 Receptor Agonists and More
https://practicaldermatology.com/conferences/maui-derm-hawaii-2026/strategies-for-treating-patients-on-glp-1-receptor-agonists-and-more/54646/Suneel Chilukuri, MD, discusses key takeaways from the “What’s My Treatment? How to Combine Dermal Filler, Neuromodulators, Laser/Light/RF Devices/Microneedling and Cosmeceuticals Symposium” workshop at Maui Derm Hawaii 2026.Rosacea: New and Old Medications, Isotretinoin, and Flushing
https://practicaldermatology.com/conferences/maui-derm-hawaii-2026/rosacea-new-and-old-medications-isotretinoin-and-flushing/54654/Hilary Baldwin, MD, discusses key takeaways from the “Acne and Rosacea: Update 2026” session at Maui Derm Hawaii 2026.New Data on Oral Therapeutics for Psoriasis
https://practicaldermatology.com/conferences/maui-derm-hawaii-2026/new-data-on-oral-therapeutics-for-psoriasis/54643/Bruce Strober, MD, PhD, discusses key takeaways from the “Acne and Rosacea: Update 2026” session at Maui Derm Hawaii 2026.